INC Research Files Registration Statement for Initial Public Offering

Article

Company News Release

INC Research Holdings, Inc. (INC Research), a leading, global Phase I to IV contract research organization, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed initial public offering of its common stock. The number of shares to be offered by INC Research

INC Research Holdings, Inc. (INC Research), a leading, global Phase I to IV contract research organization, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed initial public offering of its common stock. The number of shares to be offered by INC Research and its stockholders and the price range for the offering have not yet been determined. The Company has applied to list its common stock on The NASDAQ Global Market under the ticker symbol “INCR.” INC Research expects to use the net proceeds it receives from the offering to refinance its existing long-term debt as further specified in the registration statement.

Goldman, Sachs & Co. and Credit Suisse are serving as joint lead book-running managers for the offering. Baird, William Blair and Wells Fargo are serving as co-managers for the offering.

The offering will be made only by means of a prospectus. Once available, copies of the preliminary prospectus relating to the offering may be obtained from Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, phone: 866-471-2526, email: [email protected]; or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, phone: 800-221-1037, email: [email protected]

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.